SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-20-004558
Filing Date
2020-04-29
Accepted
2020-04-29 08:50:41
Documents
6
Period of Report
2020-06-25
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A kala-20200625xdef14a.htm DEF 14A 1200800
2 GRAPHIC kala-20200625xdef14ag001.jpg GRAPHIC 4769
3 GRAPHIC kala-20200625xdef14ag002.jpg GRAPHIC 3287
4 GRAPHIC kala-20200625xdef14ag003.jpg GRAPHIC 30109
5 GRAPHIC kala-20200625xdef14ag004.gif GRAPHIC 65233
6 GRAPHIC kala-20200625xdef14ag005.gif GRAPHIC 36620
  Complete submission text file 0001558370-20-004558.txt   1395445
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38150 | Film No.: 20827602
SIC: 2834 Pharmaceutical Preparations